|
Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
11
|
Resverlogix Corp.
|
Sep 18, 2020 06:06AM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
11
|
Resverlogix Corp.
|
Sep 18, 2020 07:09AM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
8
|
Resverlogix Corp.
|
Sep 18, 2020 07:19AM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
6
|
Resverlogix Corp.
|
Sep 19, 2020 06:37AM
|
|
Re: Wolf - A Short Summary of Statements on Partnership Discussions since 2016
|
9
|
Resverlogix Corp.
|
Sep 20, 2020 03:21AM
|
|
Re: Wolf - A Short Summary of Statements on Partnership Discussions since 2016
|
7
|
Resverlogix Corp.
|
Sep 20, 2020 03:31AM
|
|
Re: Wolf - A Short Summary of Statements on Partnership Discussions since 2016 - Trying Again
|
8
|
Resverlogix Corp.
|
Sep 20, 2020 03:56AM
|
|
Re: Don's latest presentation
|
7
|
Resverlogix Corp.
|
Sep 22, 2020 08:12PM
|
|
Synairgen update
|
|
Resverlogix Corp.
|
Sep 28, 2020 03:47AM
|
|
Two on COVID and kidneys
|
6
|
Resverlogix Corp.
|
Sep 30, 2020 07:01PM
|
|
Don Bio at Wallmine
|
4
|
Resverlogix Corp.
|
Oct 06, 2020 08:32PM
|
|
Searched forum but found no discussion of the possibility - thoughts anyone?
|
5
|
Resverlogix Corp.
|
Oct 23, 2020 08:13PM
|
|
Old News - New Article (in Cardiology Advisor dated Nov 4)
|
6
|
Resverlogix Corp.
|
Nov 05, 2020 06:58PM
|
|
Public Radio broadcast link & text - in case anyone missed it - Indirectly related - dosen't mention Apabetalone
|
5
|
Resverlogix Corp.
|
Nov 05, 2020 11:20PM
|
|
Abstracts_1 of 4: BET Protein Inhibitor Apabetalone Suppresses Inflammatory Hyperactivation of Monocytes From Patients With Cardiovascular Disease and
|
5
|
Resverlogix Corp.
|
Nov 09, 2020 03:22PM
|
|
Abstracts 2 of 4: Cardiovascular Benefits of Apabetalone: A Meta-analysis
|
6
|
Resverlogix Corp.
|
Nov 09, 2020 03:25PM
|
|
Abstracts 3 of 4: Reduction in the Risk of Major Adverse Cardiovascular Events With Apabetalone, a Bet Protein Inhibitor, in Patients With Recent Acut
|
5
|
Resverlogix Corp.
|
Nov 09, 2020 03:28PM
|
|
Abstracts 4 of 4: Apabetalone (RVX-208) Reduces ACE2 Expression in Human Cell Culture Systems, Which Could Attenuate SARS-CoV-2 Viral Entry
|
6
|
Resverlogix Corp.
|
Nov 09, 2020 03:32PM
|
|
Unrelated but interesting - a drug shown to improve eGFR in patients with Alports- wonder if there is any synergy potential here
|
|
Resverlogix Corp.
|
Nov 09, 2020 06:54PM
|
|
Various refs on COVID as a vascular /vascular endothelial disease
|
1
|
Resverlogix Corp.
|
Nov 13, 2020 09:28PM
|
